Sunridge International (OTC Bulletin Board: SNDZ), announced that China's State Food and Drug Administration, (SFDA), had approved the firm's Pneumatic Trabeculoplasty (PNT) treatment in China. In making the announcement today, Sunridge International's CEO, G. Richard Smith, said that the SFDA...